Accumulating evidence indicates that the proinflammatory cytokine IL-17 is involved in the pathogenesis of SS [50], and the pathogenic role of Th17/IL-17-producing cells in SS were demonstrated by several mouse models of SS [11]. This evidence concerns the gene IL17A and synovial sarcoma.